A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Conditions:   Chronic Plaque Psoriasis;   Moderate to Severe Chronic Plaque Psoriasis;   Psoriatic Arthritis Interventions:   Drug: Bimekizumab;   Drug: Ustekinumab;   Other: Placebo Sponsor:   UCB Biopharma S.P.R.L. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials